DARS™ Stock Ratings for AGN

If you were a Dividend.com Premium member, you would be seeing detailed DARS™ Dividend Stock Ratings information for Allergan (AGN) in this space. Sign up for Dividend.com Premium today to gain access to ratings on nearly 2,000 dividend-paying stocks, exclusive members-only articles, historical dividend information, and more!

Subscribe to Dividend.com Premium Today! »

Recent Dividend.com Articles for AGN

• Best Large Cap Dividend Stock Prospects List - Nov.14 Edition
  Sat, Nov 14, 2009
• Best Large Cap Dividend Stock Prospects List - Nov.7 Edition
  Sat, Nov 7, 2009
• ActiveStocks.com - Playbook Follow-Up
  Mon, Jul 20, 2009
• ActiveStocks.com - Paul's Playbook
  Mon, Jul 20, 2009
• Allergan Receives FDA Approval for New Eye Treatment (AGN)
  Thu, Jun 18, 2009
• Market Wrap Up for May 1
  Fri, May 1, 2009
• Market Wrap-Up for Apr.30
  Thu, Apr 30, 2009
• Dividend Highlights and Lowlights for Mar. 30
  Mon, Mar 30, 2009
• Dividend Highlights and Lowlights for Mar. 24
  Tue, Mar 24, 2009
• Dividend Highlights and Lowlights for Jan.14
  Wed, Jan 14, 2009
• Allergan Wins FDA Approval (AGN)
  Fri, Dec 26, 2008
• Allergan Study Reveals Botox Works on Migraines (AGN)
  Thu, Sep 11, 2008

Company Profile & Recommendation

Company Profile

Allergan- (AGN)-the company is a multi-specialty healthcare company, discovers, develops, and commercializes specialty pharmaceutical, medical device, and over-the-counter products for the ophthalmic, neurological, medical aesthetics(Botox), medical dermatological , breast aesthetics, obesity intervention, urological, and other specialty markets worldwide. Allergan, Inc. has strategic research collaboration agreements with ExonHit Therapeutics S.A. and Syntaxin. The company was founded in 1948 and is headquartered in Irvine, California.

* Stock price reflects previous day's closing price. All stock quotes on this website should be considered as having a 24-hour delay.

** Under no circumstances does the information in this column represent a recommendation to buy or sell stocks. The author is not registered as an investment adviser. The author may or may not hold positions in the securities mentioned in this article or video. The author relies upon the "publisher's exclusion" from the definition of "investment adviser" as provided under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws.

*** All dividend payout and date information on this website is for information purposes only. We do not guarantee the accuracy of any dividend dates or payout amounts. Always check with your broker first before purchasing any security.